a story lives forever
Sign in
Form submission failed!

Stay signed in

Recover your password?
Form submission failed!

Web of Stories Ltd would like to keep you informed about our products and services.

Please tick here if you would like us to keep you informed about our products and services.

I have read and accepted the Terms & Conditions.

Please note: Your email and any private information provided at registration will not be passed on to other individuals or organisations without your specific approval.

Video URL

You must be registered to use this feature. Sign in or register.


Partners in Health: Paul Farmer and Jim Yong Kim


The Clinical Effectiveness program
Howard Hiatt Physician
Comments (0) Please sign in or register to add comments

Shortly after the... the second year of the Clinical Effectiveness program, I went to the Dean of the School of Public Health, my successor, and suggested that we might move the program, at least in part, into the School of Public Health. He hesitated somewhat but agreed ultimately to do it, and that program has now been... become a degree-granting program at the School of Public Health and it is by far the largest degree-granting program there. It is a program that has, as I mentioned earlier, has been adopted in a Latin American version in Buenos Aires and we have some colleagues from... from Moscow, as I also mentioned, who will be starting a program at the Moscow Medical Academy fairly soon.

The program is set up in such a way that students come into it - I mention students, these students are generally people who have finished their clinical training and aspire to go onto to do clinical research, but many are far beyond that. We've had assistant professors, associate professors, and an occasional professor who comes to the program. They spend the first seven weeks of the first summer doing course work in biostatistics, in epidemiology, in decision science, and in a range of topics related in one way or another to health policy. They then return to their... their place of work where they undertake a research project that is overseen in part by somebody in their department, but in part by one member of our faculty who keeps in touch with them. And those who seek a degree come back for a second summer where they have seven weeks of intensive advanced courses in advanced science, and at that time they are eligible for a... an MPH degree in clinic... in clinical effectiveness or a Master of Science degree in clinical effectiveness. This, as I mentioned, is now by far the largest degree program at the School of Public Health and attracts extremely interesting students.

Born in 1925, American Howard Hiatt set up one of the first medical oncology research and training units in the US and has headed up some of America's most prestigious medical institutions. Hiatt attended Harvard College and received his MD from the Harvard Medical School in 1948. He was a member of the team at the Pasteur Institute, Paris, that first identified and described mRNA, and he was among the first to demonstrate mRNA in mammalian cells. From 1991 to 1997, he was Secretary of the American Academy of Arts and Sciences, where he began and directs the Academy's Initiatives For Children program. He is also committed to helping disadvantaged people access decent health care.

Listeners: Milton C. Weinstein

Milton C. Weinstein, Ph.D., is the Henry J. Kaiser Professor of Health Policy and Management at the Harvard School of Public Health and Professor of Medicine at the Harvard Medical School. At the Harvard School of Public Health he is Academic Director of the Program in Health Decision Science, and Director of the Program on Economic Evaluation of Medical Technology . He is best known for his research on cost-effectiveness of medical practices and for developing methods of economic evaluation and decision analysis in health care. He is a co-developer of the CEPAC (Cost-Effectiveness of Preventing AIDS Complications) computer simulation model, and has conducted studies on prevention and treatment of HIV infections. He is the co-developer of the Coronary Heart Disease Policy Model, which has been used to evaluate the cost-effectiveness of cardiovascular prevention and treatment. He is an author of four books: Decision Making in Health and Medicine: Integrating Evidence and Values; Cost-Effectiveness in Health and Medicine,the report of the Panel of Cost Effectiveness in Health and Medicine; Clinical Decision Analysis; and Hypertension: A Policy Perspective.He has also published more than 200 papers in peer-reviewed medical, public health, and economics journals. He is an elected member of the Institute of Medicine of the National Academy of Sciences, and a recipient of the Award for Career Achievement from the Society for Medical Decision Making. Dr. Weinstein received his A.B. and A.M. in Applied Mathematics (1970), his M.P.P. (1972), and his Ph.D. in Public Policy (1973) from Harvard University.

Tags: Clinical Effectiveness program, School of Public Health, clinical research, research project, degree

Duration: 2 minutes, 58 seconds

Date story recorded: September 2006

Date story went live: 24 January 2008